Proposal of cervical cancer early detection programme in Croatia;Prijedlog programa ranog otkrivanja raka vrata maternice U Hrvatskoj

Lijecnicki Vjesnik

Volumn 129, Issue 5, 2007, Pages 158-163

  Znaor, Ariana ^a   Babić, Damir ^b   Čorušić, Ante ^b   Grce, Magdalena ^c   Mahovlić, Vesna ^b   Pajtler, Marija ^d   Šerman, Alan ^e  

^a Hrvatski Zavod za Javno Zdravstvo   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c RUDER BO KOVI INSTITUTE   (Croatia)

^d UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^e Croatian Academy of Medical Sciences   (Croatia)

Author keywords

Diagnosis, prevention and control; national health programs; Epidemiology; Methods; Croatia; Organization and administration; mass screening; Uterine cervical neoplasms

Indexed keywords

ADULT; ARTICLE; CROATIA; EARLY DIAGNOSIS; FEMALE; HUMAN; MASS SCREENING; MIDDLE AGED; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIRUS INFECTION;

ADULT; CROATIA; EARLY DIAGNOSIS; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 34547143201     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hrvatski zavod za javno zdravstvo, Služba za epidemiologiju. Bilteni »Incidencija raka u Hrvatskoj 1999-2003« br. 24-28. Zagreb: HZJZ; 2001-2005.
2. Državni zavod za statistiku. Dokumentacija Državnog zavoda za statistiku.
3. Dekans M, Grgurević M, Tućan V, Baršić E. Važnost sistematskih pregleda u ranom otkrivanju genitalnog karcinoma. Rad Med Fak Zagreb 1957;I:32-48.
4. Ivić J, Audy S. Dosadašnji rezultati citoloških analiza u sistematskoj akciji dispanzera za zene DNZ Medveščak-Zagreb. Zdrav Nov 1976;20:98-9.
5. Dražančić A, Strnad M, Audy-Jurkovć S i sur. Pojavnost i prevencija raka ženskih spolnih organa u Hrvatskoj. U: Eljuga D, Dražančić A i sur. Prevencija i dijagnostika rumora zenskih spolnih organa. Zagreb: Nakladni zavod Globus, Hrvatsko društvo ginekologa i opsterričara, Klinika za rumore, Hrvatska liga protiv raka; 1998; 13-49.
6. World Health Organization. Health for all database. WHO, 2006.
7. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe 1995. Eur J Cancer 2002; 38: 99-166.
8. Državni zavod za statistiku. Popis stanovništva, kućanstava i stanova 2001.2. izd Zagreb: 2003.
9. Coleman D, Day N, Douglas G i sur. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme. Eur J Cancer 1993; 29A, Suppl 4: S1-S38.
10. Official Journal of the European Union. Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC).
11. Ovanin-Rakić A, Pajtler M, Stanković T, Audy-Jurković S. Klasifikacija citoloških nalaza vrata maternice »Zagreb 2002«. Modifikacija klasifikacije »Zagreb 1990« i »NCI Bethesda System 2001«. Gynecol Perinatal 2003;12:148-53.
12. Ljubojević N, Babić D, Audy-Jurković S i sur. Revidirani dijagnostićko-terapijski postupnik kod premalignih promjena vrata maternice. Gynaecol Perinatol 2001;10:85-90.
13. Pajtler M. Dijagnostička vrijednost citologije u odnosu na komplementarne metode detekcije i dijagnostike prekliničkog karcinoma vrata maternice i njegovih predstadija. Disertacija. Zagreb: Medicinski fakultet; 2001, str. 116-7.
14. Austin RM, Ramzey I. Increased detection of epithelial cells abnormalities by liquid-based gynecologic cytology preparations: a review of accumulated data. Acta Cytol 1998;42:178-84.
15. Davey E, Barratt A, Irwig L i sur. Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet 2006;367:122-32.
16. Munoz N, Bosch FX, de Sanjose S i sur. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
17. Peyton CL. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. ; Clin Microbiol 1998;36:3248-52.
18. Cuzick J, Sasieni P, Davies P i sur. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 1999;3,1-196.
19. Nindl I, Lorincz A, Mielzynska I i sur. Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation Hybrid Capture® microplate test, comparing two different cervical specimen collection methods. Clin Diagn Virol 1998;10:49-54.
20. Lorincz A, Richart R. Human Papillomavirus DNA Testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med 2003;127:959-68.
21. van Ham MA, Bakkers JM, Harbers GK i sur. Comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J Clin Microbiol 2005;43:2662-7.
22. Grce M, Husnjak K, Magdić L i sur. Detection and typing of human papillomavirus by polymerase chain reaction in cervical scrapes of Croatian women with abnormal cytology. Eur J Epidem 1997;13:645-51.
23. Kleter B, van Doom LJ, Schrauwen L i sur. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-17.
24. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using LI consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
25. Fahev MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141-.680-9.
26. Monsonego J, Bosch FX, Coursaget P i sur. Cervical cancer control, priorities and new directions. Int J Cancer 2004;108:329-33.
27. http://cancerscreening.org.uk/cervical/hpv.html
28. Cuzick J. Role of HPV testing in clinical practice. Virus Res 2002;89:263-9.
29. van den Akker-van Marie ME, van Ballegooijen M, Rozendaal L i sur. Extended duration of the detectable stage by adding HPV test in cervical cancer screening. Br J Cancer 2003;89:1830-3.
30. Hakama M. Planning and designing of screening programmes. U: Sankila R, Demaret E, Hakama M, Lynge E, Scheuten LJ, Parkin DM, (ur.). Evaluation and monitoring of screening programmes. Brussels: European Commission, Europe against cancer program; 2000.
31. Linos A, Riza E, van Ballegooijen M (urednici). Special issue: Cervical cancer screening in the European Union. Eur J Cancer 2000;17:2175-275.
32. Mackenzie EFD, Chapman PA, Codling BW i sur. Recommended code of practice for laboratories providing a cytopathology service 1997. Cytopathology 1997;8(Suppl 1): S1-S25.
33. Wied GL, Bibbo M, Keebler CM. Diagnostic quality assurance in cytopathology. U: Bibbo M, ur. Comprehensive cytopathology, 2. izd. Philadelphia: WB Saunders Company; 1997, str. 63-7.
34. Audy-Jurković S, Ivić J, Sips Šips cross D sign i sur. Testiranje vještine u ginekološkoj citodijagnostici u Zagrebu. Jug Ginekol Perinatol 1988;28:83-8.